600
Participants
Start Date
July 29, 2022
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2027
Risdiplam
Risdiplam
Nusinersen Injectable Product
Nusinersen
RECRUITING
University Hospitals Birmingham NHS Foundation Trust, Birmingham
RECRUITING
North Bristol NHS Trust, Bristol
RECRUITING
Cambridge University Hospitals NHS Foundation Trust, Cambridge
RECRUITING
Cardiff and Vale University Health Board, Cardiff
RECRUITING
NHS Greater Glasgow and Clyde, Glasgow
RECRUITING
Bradford Teaching Hospitals NHS Foundation Trust, Leeds
RECRUITING
The Walton Centre NHS Foundation Trust, Liverpool
RECRUITING
University College London Hospitals NHS Foundation Trust, London
RECRUITING
King's College Hospital NHS Foundation Trust, London
RECRUITING
St George's University NHS Foundation Trust, London
RECRUITING
Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle upon Tyne
RECRUITING
Nottingham University Hospitals Trust, Nottingham
RECRUITING
The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry
RECRUITING
Oxford University Hospitals Trust, Oxford
RECRUITING
The Northern Care Alliance NHS Foundation Trust, Salford
RECRUITING
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
RECRUITING
University Hospital Southampton NHS Foundation Trust, Southampton
RECRUITING
South West Wales Neuromuscular Service in Swansea, Swansea
Collaborators (1)
Newcastle University
OTHER
John Walton Muscular Dystrophy Research Centre
UNKNOWN
Biogen
INDUSTRY
Roche Products Limited
UNKNOWN
Newcastle-upon-Tyne Hospitals NHS Trust
OTHER